
Join to View Full Profile
14200 W. Celebrate Life Way.Goodyear, AZ 85338
Phone+1 602-883-1259
Dr. Bryce is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2006 - 2009
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2003 - 2006
- Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2003, MD
- UCLABS, Biochemistry , 1994 - 1998
Certifications & Licensure
- CA State Medical License 2009 - Present
- UT State Medical License 2025 - 2028
- AZ State Medical License 2011 - 2027
- CO State Medical License 2025 - 2027
- NV State Medical License 2025 - 2027
- NM State Medical License 2025 - 2026
- MN State Medical License 2004 - 2009
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab Start of enrollment: 2018 Apr 24
- A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer Start of enrollment: 2018 Nov 26
- Camostat Mesilate Treating Patients With Hospitalized Patients With COVID-19 Start of enrollment: 2020 Jul 28
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsGermline and somatic testing for homologous repair deficiency in patients with prostate cancer (part 1 of 2).Andrew J Armstrong, Amy Taylor, Michael C Haffner, Wassim Abida, Alan H Bryce
Prostate Cancer and Prostatic Diseases. 2025-09-01 - 3 citationsTherapeutic implications of homologous repair deficiency testing in patients with prostate cancer (Part 2 of 2).Anthony V Serritella, Amy Taylor, Michael C Haffner, Wassim Abida, Alan Bryce
Prostate Cancer and Prostatic Diseases. 2025-09-01 - Prostate Cancer Foundation White Paper on Combination Therapy for Metastatic Hormone-Sensitive Prostate Cancer.Sigrid V Carlsson, Pedro C Barata, Alan H Bryce, Daniel J George, Silke Gillessen
JCO Oncology Practice. 2025-09-01
Journal Articles
- Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients with Hereditary Cancer SyndromeScott Okuno, Luke Mountjoy, Cameron S Thorpe, Edward D Esplin, Robert L Nussbaum, Alan H Bryce, Tanios S Bekaii-Saab, Aleksandar Sekulic, JAMA Oncology
Lectures
- Patterns of PSA versus clinically progressive disease in the E3805 CHAARTED trial.2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
- Clinical Hematology and Oncology 2013: The 10th Annual Mayo Board ReviewMayo School of Continuous Professional Development, Scottsdale, Arizona - 1/18/2013
Press Mentions
- What 17 Leaders Wish Medical Students Learned About Cancer CareSeptember 10th, 2025
- Systemwide Commitment to Prevention Is ‘Fundamental’, Per 1 City of Hope LeaderSeptember 3rd, 2025
- Insights from ASCO 2025: Real-World Evidence Drives Clinical Decision-MakingJune 13th, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: